MARKET
-
Tired of nausea or taking a GLP-1 pill every day? These experimental drugs could be better than Zepbound and Wegovy.
There is a new wave of weight-loss therapies in development that aim to be better than the existing GLP-1s. Source…
Read More » -
Only 5% of day traders make money, but the SEC is now making it easier for more people to try it anyway
The pattern day-trading rule is going away on June 4, but retail investors should understand the risks. Source link
Read More » -
It’s not just tech stocks: The broad-based strength of the market right now gives investors reason to stay the course
While tech is still leading the party, more parts of the market are starting to join in. Source link
Read More » -
The number of 401(k) millionaires just fell — but workers hit record savings rates. What’s going on?
Fidelity’s first-quarter data shows 401(k) balances dipping — but it’s not all bad news. Source link
Read More » -
I’m 67. Our family trust earns $300,000 annually for my kids. How do I ensure they won’t get killed on taxes?
“My thought is to distribute all of the income to my children each year so that the trust itself pays…
Read More » -
Americans are paying $2 billion more for gas this Memorial Day weekend than they did last year
The unofficial start of the summer travel season marks a major test for consumers and the economy. And the pressures…
Read More » -
Elon Musk ditched California, but the state will get a much-needed win from SpaceX’s IPO
Elon Musk stormed out of the state and took the headquarters of SpaceX and Tesla with him. But many current…
Read More » -
5 money moves that made this 32-year-old dad a millionaire in just 9 years
A low starting salary, global pandemic, unaffordable housing market, graduate school and two kids didn’t stop Blake Edwards and his…
Read More » -
5 tests Kevin Warsh will face as Fed chair
Wall Street and Washington will be watching to see how he reacts to political pressure and whether he can get…
Read More » -
As Nvidia earnings draw closer, here are 5 things investors need to watch
The chip maker’s stock has been a laggard — but Goldman Sachs sees five potential catalysts that could come out…
Read More »